ArticleNPJ precision oncology2021

Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition.

Niamh Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.